0

Purchase Short-Term Access

Patients Exposed to Rofecoxib and Celecoxib Have Different Odds of Nonfatal Myocardial Infarction
Stephen E. Kimmel, MD, MSCE; Jesse A. Berlin, ScD; Muredach Reilly, MB; Jane Jaskowiak, BSN, RN; Lori Kishel, MS; Jesse Chittams, MS; Brian L. Strom, MD, MPH
Annals of Internal Medicine 2005;142:157-164. doi:10.7326/0003-4819-142-3-200502010-00005

Purchase Online access to this article for 24 hours
Buy Now
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)